Published in Science on August 06, 1993
Cytochromes P450: a success story. Genome Biol (2000) 3.08
Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci U S A (2001) 2.90
Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am J Hum Genet (1998) 2.31
Structure of a cytochrome P450-redox partner electron-transfer complex. Proc Natl Acad Sci U S A (1999) 2.30
Single-molecule height measurements on microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks. Proc Natl Acad Sci U S A (2002) 1.98
Structure-guided recombination creates an artificial family of cytochromes P450. PLoS Biol (2006) 1.90
CYP703 is an ancient cytochrome P450 in land plants catalyzing in-chain hydroxylation of lauric acid to provide building blocks for sporopollenin synthesis in pollen. Plant Cell (2007) 1.69
The structural basis for substrate anchoring, active site selectivity, and product formation by P450 PikC from Streptomyces venezuelae. J Biol Chem (2006) 1.59
Clusters of charged residues in protein three-dimensional structures. Proc Natl Acad Sci U S A (1996) 1.50
Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. Environ Health Perspect (1998) 1.46
Comparison of the dynamics of substrate access channels in three cytochrome P450s reveals different opening mechanisms and a novel functional role for a buried arginine. Proc Natl Acad Sci U S A (2002) 1.44
Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine. Nat Biotechnol (2010) 1.42
Epoxidation of olefins by cytochrome P450: evidence from site-specific mutagenesis for hydroperoxo-iron as an electrophilic oxidant. Proc Natl Acad Sci U S A (1998) 1.40
Conformational plasticity and structure/function relationships in cytochromes P450. Antioxid Redox Signal (2010) 1.40
Probing the open state of cytochrome P450cam with ruthenium-linker substrates. Proc Natl Acad Sci U S A (2001) 1.33
A three-dimensional model of aromatase cytochrome P450. Protein Sci (1995) 1.30
Structural insights from a P450 Carrier Protein complex reveal how specificity is achieved in the P450(BioI) ACP complex. Proc Natl Acad Sci U S A (2008) 1.29
Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families. Am J Hum Genet (1998) 1.29
Cytochrome P450 flexibility. Proc Natl Acad Sci U S A (2003) 1.27
MOLE 2.0: advanced approach for analysis of biomacromolecular channels. J Cheminform (2013) 1.26
Differential expression and evolution of the Arabidopsis CYP86A subfamily. Plant Physiol (2005) 1.25
Identification of a functional water channel in cytochrome P450 enzymes. Proc Natl Acad Sci U S A (1997) 1.24
Diversification of furanocoumarin-metabolizing cytochrome P450 monooxygenases in two papilionids: Specificity and substrate encounter rate. Proc Natl Acad Sci U S A (2003) 1.19
X-ray structure of human aromatase reveals an androgen-specific active site. J Steroid Biochem Mol Biol (2009) 1.18
Structural diversity of eukaryotic membrane cytochrome p450s. J Biol Chem (2013) 1.18
Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cells. J Physiol (1998) 1.17
Roles of key active-site residues in flavocytochrome P450 BM3. Biochem J (1999) 1.16
Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1.93 A resolution. Protein Sci (1999) 1.10
Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules. Biochemistry (2012) 1.08
Structural insights into diversity and n-alkane biodegradation mechanisms of alkane hydroxylases. Front Microbiol (2013) 1.06
Investigating the structural plasticity of a cytochrome P450: three-dimensional structures of P450 EryK and binding to its physiological substrate. J Biol Chem (2009) 1.06
Molecular modeling of cytochrome P450 3A4. J Comput Aided Mol Des (1997) 1.04
Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution. Nat Chem (2011) 1.00
A single amino acid substitution (F363I) converts the regiochemistry of the spearmint (-)-limonene hydroxylase from a C6- to a C3-hydroxylase. Proc Natl Acad Sci U S A (2000) 0.99
Controlled oxidation of remote sp3 C-H bonds in artemisinin via P450 catalysts with fine-tuned regio- and stereoselectivity. J Am Chem Soc (2012) 0.99
Elucidating the role of the proximal cysteine hydrogen-bonding network in ferric cytochrome P450cam and corresponding mutants using magnetic circular dichroism spectroscopy. Biochemistry (2011) 0.97
Three-dimensional model of lanosterol 14 alpha-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding. Antimicrob Agents Chemother (2009) 0.96
Microsomal monooxygenase as a multienzyme system: the role of P450-P450 interactions. Expert Opin Drug Metab Toxicol (2011) 0.94
Crystal structure of H2O2-dependent cytochrome P450SPalpha with its bound fatty acid substrate: insight into the regioselective hydroxylation of fatty acids at the alpha position. J Biol Chem (2011) 0.93
Genome-wide identification and characterization of putative cytochrome P450 genes in the model legume Medicago truncatula. Planta (2007) 0.93
CYP63A2, a catalytically versatile fungal P450 monooxygenase capable of oxidizing higher-molecular-weight polycyclic aromatic hydrocarbons, alkylphenols, and alkanes. Appl Environ Microbiol (2013) 0.92
Engineering the substrate specificity of Bacillus megaterium cytochrome P-450 BM3: hydroxylation of alkyl trimethylammonium compounds. Biochem J (1997) 0.92
Electrochemical detection of anti-breast-cancer agents in human serum by cytochrome P450-coated carbon nanotubes. Sensors (Basel) (2012) 0.92
Molecular dynamics study of time-correlated protein domain motions and molecular flexibility: cytochrome P450BM-3. Biophys J (1997) 0.91
Identification of the domains of neuronal nitric oxide synthase by limited proteolysis. Biochem J (1996) 0.90
Structural motif-based homology modeling of CYP27A1 and site-directed mutational analyses affecting vitamin D hydroxylation. Biophys J (2006) 0.89
Modes of heme binding and substrate access for cytochrome P450 CYP74A revealed by crystal structures of allene oxide synthase. Proc Natl Acad Sci U S A (2008) 0.89
Substrate access channel topology in membrane-bound prostacyclin synthase. Biochem J (2002) 0.88
Influence of phenylalanine-481 substitutions on the catalytic activity of cytochrome P450 2D6. Biochem J (2001) 0.88
Covalent modification of Thr302 in cytochrome P450 2B1 by the mechanism-based inactivator 4-tert-butylphenylacetylene. J Pharmacol Exp Ther (2010) 0.87
Experimental documentation of the structural consequences of hydrogen-bonding interactions to the proximal cysteine of a cytochrome P450. Angew Chem Int Ed Engl (2012) 0.86
3D-QSAR methods on the basis of ligand-receptor complexes. Application of COMBINE and GRID/GOLPE methodologies to a series of CYP1A2 ligands. J Comput Aided Mol Des (2000) 0.86
Mutation T318M in the CYP11B2 gene encoding P450c11AS (aldosterone synthase) causes corticosterone methyl oxidase II deficiency. Am J Hum Genet (1995) 0.85
Theoretical investigation of substrate specificity for cytochromes P450 IA2, P450 IID6 and P450 IIIA4. J Comput Aided Mol Des (2000) 0.85
Determinants of the substrate specificity of human cytochrome P-450 CYP2D6: design and construction of a mutant with testosterone hydroxylase activity. Biochem J (1998) 0.85
Combining substrate dynamics, binding statistics, and energy barriers to rationalize regioselective hydroxylation of octane and lauric acid by CYP102A1 and mutants. Protein Sci (2007) 0.84
Influence of amino acid residue 374 of cytochrome P-450 2D6 (CYP2D6) on the regio- and enantio-selective metabolism of metoprolol. Biochem J (1996) 0.84
Solution structure and topology of the N-terminal membrane anchor domain of a microsomal cytochrome P450: prostaglandin I2 synthase. Biochem J (2002) 0.84
Novel CYP11B2 mutation causing aldosterone synthase (P450c11AS) deficiency. Eur J Pediatr (2012) 0.84
Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions. Br J Pharmacol (2007) 0.84
Control of androgen biosynthesis in the human through the interaction of Arg347 and Arg358 of CYP17 with cytochrome b5. Biochem J (1998) 0.83
The critical role of substrate-protein hydrogen bonding in the control of regioselective hydroxylation in p450cin. J Biol Chem (2008) 0.83
Correlating structure and function of drug-metabolizing enzymes: progress and ongoing challenges. Drug Metab Dispos (2013) 0.82
The role of tryptophan 97 of cytochrome P450 BM3 from Bacillus megaterium in catalytic function. Evidence against the 'covalent switching' hypothesis of P-450 electron transfer. Biochem J (1994) 0.82
Evolutionarily divergent electron donor proteins interact with P450MT2 through the same helical domain but different contact points. EMBO J (2001) 0.81
Inhibitors of aromatase prevent degradation of the enzyme in cultured human tumour cells. Br J Cancer (1998) 0.81
Effect of the disease-causing R266K mutation on the heme and PLP environments of human cystathionine β-synthase. Biochemistry (2012) 0.81
Characterization of the basic replicon of Rhodococcus plasmid pSOX and development of a Rhodococcus-Escherichia coli shuttle vector. Appl Environ Microbiol (1998) 0.80
Structural and functional analysis of a novel mutation of CYP21B in a heterozygote carrier of 21-hydroxylase deficiency. Hum Genet (2005) 0.80
Wild-type CYP102A1 as a biocatalyst: turnover of drugs usually metabolised by human liver enzymes. J Biol Inorg Chem (2007) 0.80
A 53-base-pair inverted repeat negatively regulates expression of the adjacent and divergently oriented cytochrome P450(BM-1) gene and its regulatory gene, bm1P1, in Bacillus megaterium. J Bacteriol (1997) 0.79
Optimization of the bacterial cytochrome P450 BM3 system for the production of human drug metabolites. Int J Mol Sci (2012) 0.79
Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias. J Biol Chem (2013) 0.79
Delineation of the arginine- and tetrahydrobiopterin-binding sites of neuronal nitric oxide synthase. Biochem J (1997) 0.79
Explicit water near the catalytic I helix Thr in the predicted solution structure of CYP2A4. Biophys J (2003) 0.78
Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6. Biochem J (2000) 0.78
Fatty acid-induced alteration of the porphyrin macrocycle of cytochrome P450 BM3. Biophys J (1998) 0.78
Conformational Distortions of π-Cation Radical (β-Oxoporphyrin)copper(II) Derivatives: [Cu(2,7,12-TrioxoOEHP)][SbCl(6)] and [Cu(2,7-DioxoOEiBC)][SbCl(6)]. J Porphyr Phthalocyanines (2011) 0.78
Lysine mutagenesis identifies cationic charges of human CYP17 that interact with cytochrome b5 to promote male sex-hormone biosynthesis. Biochem J (1999) 0.78
Function and membrane topology of wild-type and mutated cytochrome P-450c21. Biochem J (1996) 0.78
Characterization of diverse natural variants of CYP102A1 found within a species of Bacillus megaterium. AMB Express (2011) 0.78
Recent Structural Insights into Cytochrome P450 Function. Trends Pharmacol Sci (2016) 0.77
Cytochrome P450 102A2 Catalyzes Efficient Oxidation of Sodium Dodecyl Sulphate: A Molecular Tool for Remediation. Enzyme Res (2010) 0.77
S279 point mutations in Candida albicans Sterol 14-α demethylase (CYP51) reduce in vitro inhibition by fluconazole. Antimicrob Agents Chemother (2012) 0.77
Three-dimensional modelling of human cytochrome P450 1A2 and its interaction with caffeine and MeIQ. J Comput Aided Mol Des (1997) 0.77
Dynamics and flexibility of human aromatase probed by FTIR and time resolved fluorescence spectroscopy. PLoS One (2013) 0.77
Effect of replacement of ferriprotoporphyrin IX in the haem domain of cytochrome P-450 BM-3 on substrate binding and catalytic activity. Biochem J (1995) 0.77
Functioning of drug-metabolizing microsomal cytochrome P450s: In silico probing of proteins suggests that the distal heme 'active site' pocket plays a relatively 'passive role' in some enzyme-substrate interactions. In Silico Pharmacol (2016) 0.76
Physical Studies of P450-P450 Interactions: Predicting Quaternary Structures of P450 Complexes in Membranes from Their X-ray Crystal Structures. Front Pharmacol (2017) 0.75
Functional Significance of Cytochrome P450 1A2 Allelic Variants, P450 1A2*8, *15, and *16 (R456H, P42R, and R377Q). Biomol Ther (Seoul) (2015) 0.75
Comparison of intrinsic dynamics of cytochrome p450 proteins using normal mode analysis. Protein Sci (2015) 0.75
P450BM3 fused to phosphite dehydrogenase allows phosphite-driven selective oxidations. Appl Microbiol Biotechnol (2016) 0.75
Structural insights into the function of steroidogenic cytochrome P450 17A1. Mol Cell Endocrinol (2016) 0.75
Ab initio calculations on iron-porphyrin model systems for intermediates in the oxidative cycle of cytochrome P450s. J Comput Aided Mol Des (1998) 0.75
Mutation THR-185 ILE is associated with corticosterone methyl oxidase deficiency type II. Eur J Pediatr (1998) 0.75
X-ray structure analysis of a membrane protein complex. Electron density map at 3 A resolution and a model of the chromophores of the photosynthetic reaction center from Rhodopseudomonas viridis. J Mol Biol (1984) 8.85
The leucine-rich repeat: a versatile binding motif. Trends Biochem Sci (1994) 7.37
Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry (1981) 6.13
Crystal structure of the outer membrane active transporter FepA from Escherichia coli. Nat Struct Biol (1999) 4.86
A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature (1995) 4.70
Crystal structure of DNA photolyase from Escherichia coli. Science (1995) 4.21
Crystal structure of the cytochrome bc1 complex from bovine heart mitochondria. Science (1997) 4.07
Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer (1981) 3.90
Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol (1984) 3.60
Structural mechanism for statin inhibition of HMG-CoA reductase. Science (2001) 3.45
Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.0 A resolution. J Mol Biol (1980) 3.25
Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature (1994) 3.24
Proteins with leucine-rich repeats. Curr Opin Struct Biol (1995) 3.18
Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution. J Mol Biol (1974) 3.17
Unique biochemical events in bacterial sporulation. Annu Rev Microbiol (1970) 3.11
Crystallographic structure studies of an IgG molecule and an Fc fragment. Nature (1976) 3.00
Pigment-protein interactions in the photosynthetic reaction centre from Rhodopseudomonas viridis. EMBO J (1986) 2.85
Enzymatic omega-oxidation. I. Electon carriers in fatty acid and hydrocarbon hydroxylation. J Biol Chem (1966) 2.83
Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution. Structure (1994) 2.80
Structure and function of cytochromes P450: a comparative analysis of three crystal structures. Structure (1995) 2.64
Enzymatic omega-oxidation. II. Function of rubredoxin as the electron carrier in omega-hydroxylation. J Biol Chem (1967) 2.62
Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli. J Virol (1994) 2.56
An exploration of the activity theory of aging: activity types and life satisfaction among in-movers to a retirement community. J Gerontol (1972) 2.49
Convergent and alternative designs in the digital adhesive pads of scincid lizards. Science (1982) 2.34
Structure of a cytochrome P450-redox partner electron-transfer complex. Proc Natl Acad Sci U S A (1999) 2.30
The crystal structure of the GroES co-chaperonin at 2.8 A resolution. Nature (1996) 2.25
Surface differentiation antigens of human mammary epithelial cells carried on the human milk fat globule. Proc Natl Acad Sci U S A (1977) 2.16
Structural homology of reaction centers from Rhodopseudomonas sphaeroides and Rhodopseudomonas viridis as determined by x-ray diffraction. Proc Natl Acad Sci U S A (1986) 2.16
The Photosynthetic Reaction Center from the Purple Bacterium Rhodopseudomonas viridis. Science (1989) 2.13
Analysis of optical spectra from single crystals of Rhodopseudomonas viridis reaction centers. Proc Natl Acad Sci U S A (1985) 2.11
Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet (1998) 2.07
Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP. Cancer Res (2000) 1.91
Expression of differentiated functions in hepatoma cell hybrids: induction of mouse albumin production in rat hepatoma-mouse fibroblast hybrids. Proc Natl Acad Sci U S A (1972) 1.90
Crystal structures of mitochondrial processing peptidase reveal the mode for specific cleavage of import signal sequences. Structure (2001) 1.81
Pivotal role of water in the mechanism of P450BM-3. Biochemistry (2001) 1.81
Climate change and the integrity of science. Science (2010) 1.80
Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis. EMBO J (2000) 1.79
Craniosynostosis, midfacial hypoplasia and foot abnormalities: an autosomal dominant phenotype in a large Amish kindred. J Pediatr (1976) 1.77
Comparison of two highly refined structures of bovine pancreatic trypsin inhibitor. J Mol Biol (1987) 1.77
Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A. J Mol Biol (1996) 1.70
Crystal structure and refinement of cytochrome P450terp at 2.3 A resolution. J Mol Biol (1994) 1.70
Transmission of experimental rhinovirus colds in volunteer married couples. J Infect Dis (1976) 1.66
Inhibitor binding changes domain mobility in the iron-sulfur protein of the mitochondrial bc1 complex from bovine heart. Proc Natl Acad Sci U S A (1998) 1.65
Medicaid in the inner city: the case of maternity care in Chicago. Milbank Q (1990) 1.62
The structure of the ligand-binding domain of neurexin Ibeta: regulation of LNS domain function by alternative splicing. Cell (1999) 1.61
Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J Clin Invest (1992) 1.60
Surface protein-CAT reporter fusions demonstrate differential gene expression in the vir regulon of Streptococcus pyogenes. Mol Microbiol (1992) 1.59
APC2 Cullin protein and APC11 RING protein comprise the minimal ubiquitin ligase module of the anaphase-promoting complex. Mol Biol Cell (2001) 1.59
How similar are P450s and what can their differences teach us? Arch Biochem Biophys (1999) 1.57
Crystal structure of the DNA nucleotide excision repair enzyme UvrB from Thermus thermophilus. Proc Natl Acad Sci U S A (1999) 1.56
Physician supply and Medicaid participation. The causes of market failure. Med Care (1989) 1.56
Enzymatic omega-oxidation. 3. Purification and properties of rubredoxin, a component of the omega-hydroxylation system of Pseudomonas oleovorans. J Biol Chem (1968) 1.56
A Mr 46,000 human milk fat globule protein that is highly expressed in human breast tumors contains factor VIII-like domains. Cancer Res (1991) 1.50
The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3. J Biol Chem (1996) 1.48
Structure of the human antibody molecule Kol (immunoglobulin G1): an electron density map at 5 A resolution. J Mol Biol (1976) 1.47
Medicaid and access to child health care in Chicago. J Health Polit Policy Law (1992) 1.45
Lactadherin (formerly BA46), a membrane-associated glycoprotein expressed in human milk and breast carcinomas, promotes Arg-Gly-Asp (RGD)-dependent cell adhesion. DNA Cell Biol (1997) 1.43
Ligand binding to heme proteins. An evaluation of distal effects. J Biol Chem (1983) 1.42
Crystal structure analysis and molecular model of a complex of citrate synthase with oxaloacetate and S-acetonyl-coenzyme A. J Mol Biol (1984) 1.41
Crystallization, crystal structure analysis and atomic model of the complex formed by a human Fc fragment and fragment B of protein A from Staphylococcus aureus. Hoppe Seylers Z Physiol Chem (1978) 1.40
Chromophore-protein interactions and the function of the photosynthetic reaction center: a molecular dynamics study. Proc Natl Acad Sci U S A (1992) 1.40
Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3. Cell (1995) 1.37
The crystal structure of the bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase reveals distinct domain homologies. Structure (1996) 1.30
A three-dimensional model of aromatase cytochrome P450. Protein Sci (1995) 1.30
Synapsin I is structurally similar to ATP-utilizing enzymes. EMBO J (1998) 1.27
Dynamics of the aromatic amino acid residues in the globular conformation of the basic pancreatic trypsin inhibitor (BPTI). II. Semi-empirical energy calculations. Biophys Struct Mech (1976) 1.26
Crystal structure analysis and molecular model of human C3a anaphylatoxin. Hoppe Seylers Z Physiol Chem (1980) 1.25
Crystal structure of Rab geranylgeranyltransferase at 2.0 A resolution. Structure (2000) 1.21
Temperature dependence of cytochrome P-450 reduction. A model for NADPH-cytochrome P-450 reductase:cytochrome P-450 interaction. J Biol Chem (1976) 1.20
Oxygenated cytochrome P-450 and its possible role in enzymic hydroxylation. Biochem Biophys Res Commun (1971) 1.17
An active site substitution, F87V, converts cytochrome P450 BM-3 into a regio- and stereoselective (14S,15R)-arachidonic acid epoxygenase. J Biol Chem (1997) 1.17
Cytochrome content of two pseudomonads containing mixed-function oxidase systems. J Bacteriol (1970) 1.15
An N-methyl glutamate dehydrogenase from Pseudomonas M.A. Arch Biochem Biophys (1971) 1.14
Medicaid patients' access to office-based obstetricians. J Health Care Poor Underserved (1991) 1.14
Changes in cytochrome content and electron transport patterns in Pseudomonas putida as a function of growth phase. J Bacteriol (1978) 1.13
The plug domain of FepA, a TonB-dependent transport protein from Escherichia coli, binds its siderophore in the absence of the transmembrane barrel domain. Proc Natl Acad Sci U S A (2001) 1.12
Experience with various techniques for the refinement of protein structures. Methods Enzymol (1985) 1.12
Crystallographic structural studies of a human Fc fragment. II. A complete model based on a Fourier map at 3.5 A resolution. Hoppe Seylers Z Physiol Chem (1976) 1.12
Fatty acid monooxygenation by cytochrome P-450BM-3. J Biol Chem (1990) 1.12
Structural alignments of P450s and extrapolations to the unknown. Methods Enzymol (1996) 1.10
Ring 1 chromosome and dwarfism--a possible syndrome. J Pediatr (1967) 1.09
Mechanism of Rab geranylgeranylation: formation of the catalytic ternary complex. Biochemistry (1998) 1.08
Structural adaptations in the specialized bacteriophage T4 co-chaperonin Gp31 expand the size of the Anfinsen cage. Cell (1997) 1.06
Camphor binding by Pseudomonas putida cytochrome P-450. Kinetics and thermodynamics of the reaction. Biochemistry (1972) 1.06
Purification of bacterial cytochrome P-450. Methods Enzymol (1978) 1.03
Nitration and inactivation of cytochrome P450BM-3 by peroxynitrite. Stopped-flow measurements prove ferryl intermediates. Eur J Biochem (2000) 1.03
Single turnover kinetics of the reaction between oxycytochrome P-450cam and reduced putidaredoxin. J Biol Chem (1988) 1.01
EPR-spectroscopy of reduced oxyferrous-P450cam. FEBS Lett (1991) 1.01
Studies of the oxygen binding site of cytochrome P-450. Nitric oxide as a spin-label probe. J Biol Chem (1978) 1.00
Cloning and sequence analysis of human breast epithelial antigen BA46 reveals an RGD cell adhesion sequence presented on an epidermal growth factor-like domain. DNA Cell Biol (1996) 0.99
P450s: structural similarities and functional differences. FASEB J (1996) 0.99
Characterization of cell surface antigens of human mammary epithelial cells with monoclonal antibodies prepared against human milk fat globule. Somatic Cell Genet (1983) 0.98
The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains. Biochemistry (1996) 0.96
NMR study in the iron-selenide Rb0.74Fe1.6Se2: determination of the superconducting phase as iron vacancy-free Rb0.3Fe2Se2. Phys Rev Lett (2012) 0.96
The structure of the catalytic portion of human HMG-CoA reductase. Biochim Biophys Acta (2000) 0.95
Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3. Biochemistry (1996) 0.94